Clinical trial
Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma
NCT06788353 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma
- Lead sponsor
- Sun Yat-sen University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 1, 2023
- Completion date
- March 1, 2027
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
systemic therapy, transarterial chemoembolization, unresectable hepatocellular carcinoma